Taser back in 2003 had what was considered a tiny float of 2.2 million shares. Taser traded from around $4.00 to more than $82 during 2003 and continued to reach new highs surpassing $150/share. Taser currently has a market cap of around $3 Billion.
Tilray has a public float of about 17.8 million shares and IPO'ed around $17/share and hit a high of $300/share last year. Tilray currently has a market cap of around $7 Billion.
Lifeloc has a public float that would be considered miniscule by anyone's standards. It is considerably less than that of Taser and Tilray. Lifeloc has similar revenue numbers to that of Taser in 2003. I believe the marijuana breathalyzer will be comparable to that of the Taser in it's early years. Tremendous growth potential, barriers to entry are high, unique product, demand for the product is coming from all areas of the planet, etc.
If we were to ever see Lifeloc with a similar market cap to that of Taser, (assuming the shares outstanding stay the same) Lifeloc would trade at $120,000/share. This may sound absurd but a marijuana breathalyzer has similar potential to that of the Taser stun gun. Is it out of the realm of possibilities - not really. Lifeloc's float could be swallowed up quickly if news of a working and reliable marijuana breathalyzer was realized. Sky is the limit when the entire float becomes locked up and everyone is scrambling for shares of the next Taser or Tilray.
Good luck to all involved!
